Literature DB >> 19376076

Epidemiological situation of malaria in Madagascar: baseline data for monitoring the impact of malaria control programmes using serological markers.

Romy Razakandrainibe1, Vincent Thonier, Arsène Ratsimbasoa, Emma Rakotomalala, Elisabeth Ravaoarisoa, Rogelin Raherinjafy, Herilalaina Andrianantenaina, Odette Voahanginirina, Tiana Eugénie Rahasana, Jean François Carod, Olivier Domarle, Didier Menard.   

Abstract

The aim of this study was to provide baseline information of the epidemiological situation of malaria in Madagascar using serological markers. We carried out cross-sectional studies in schoolchildren from eight sites in the four different malarious epidemiological strata of Madagascar. We studied the prevalence of anti-MSP1 antibodies to assess the burden, and anti-CSP antibodies to estimate the transmission intensity, of malaria. The overall prevalence of each antibody tested was 46.1% for anti-PfMSP-1, 15.2% for anti-PvMSP-1, 14.9% for anti-PfCSP, 4.9% for anti-PvCSP and 2.4% for anti-PmCSP. The prevalence of the five antibodies varied significantly between the sites (P<10(-6)). We also found significant effects of ethnic origin on the prevalence of anti-PfMSP1 antibodies. With regular testing in the same target populations, this data will be particularly useful for managing the elimination strategy supported by the Malagasy Government.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19376076     DOI: 10.1016/j.actatropica.2009.04.007

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  13 in total

1.  Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy people.

Authors:  Didier Ménard; Céline Barnadas; Christiane Bouchier; Cara Henry-Halldin; Laurie R Gray; Arsène Ratsimbasoa; Vincent Thonier; Jean-François Carod; Olivier Domarle; Yves Colin; Olivier Bertrand; Julien Picot; Christopher L King; Brian T Grimberg; Odile Mercereau-Puijalon; Peter A Zimmerman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-15       Impact factor: 11.205

2.  Chloroquine clinical failures in P. falciparum malaria are associated with mutant Pfmdr-1, not Pfcrt in Madagascar.

Authors:  Valérie Andriantsoanirina; Arsène Ratsimbasoa; Christiane Bouchier; Magali Tichit; Martial Jahevitra; Stéphane Rabearimanana; Rogelin Raherinjafy; Odile Mercereau-Puijalon; Rémy Durand; Didier Ménard
Journal:  PLoS One       Date:  2010-10-13       Impact factor: 3.240

3.  Management of uncomplicated malaria in febrile under five-year-old children by community health workers in Madagascar: reliability of malaria rapid diagnostic tests.

Authors:  Arsène Ratsimbasoa; Harintsoa Ravony; Jeanne-Aimée Vonimpaisomihanta; Rogelin Raherinjafy; Martial Jahevitra; Rabenja Rapelanoro; Jean De Dieu Marie Rakotomanga; Denis Malvy; Pascal Millet; Didier Ménard
Journal:  Malar J       Date:  2012-03-25       Impact factor: 2.979

4.  Plasmodium vivax sub-patent infections after radical treatment are common in Peruvian patients: results of a 1-year prospective cohort study.

Authors:  Peter Van den Eede; Veronica E Soto-Calle; Christopher Delgado; Dionicia Gamboa; Tanilu Grande; Hugo Rodriguez; Alejandro Llanos-Cuentas; Jozef Anné; Umberto D'Alessandro; Annette Erhart
Journal:  PLoS One       Date:  2011-01-28       Impact factor: 3.240

5.  Human saliva as a source of anti-malarial antibodies to examine population exposure to Plasmodium falciparum.

Authors:  Patricia Tabernero Estévez; Judith Satoguina; Davis C Nwakanma; Sheila West; David J Conway; Chris J Drakeley
Journal:  Malar J       Date:  2011-04-29       Impact factor: 2.979

6.  Sero-epidemiological evaluation of Plasmodium falciparum malaria in Senegal.

Authors:  Khadime Sylla; Roger Clément Kouly Tine; Magatte Ndiaye; Doudou Sow; Aïssatou Sarr; Marie Louise Tshibola Mbuyi; Ibrahima Diouf; Amy Colé Lô; Annie Abiola; Mame Cheikh Seck; Mouhamadou Ndiaye; Aïda Sadikh Badiane; Jean Louis A N'Diaye; Daouda Ndiaye; Oumar Faye; Thérèse Dieng; Yémou Dieng; Oumar Ndir; Oumar Gaye; Babacar Faye
Journal:  Malar J       Date:  2015-07-16       Impact factor: 2.979

7.  Dramatic declines in seropositivity as determined with crude extracts of Plasmodium falciparum schizonts between 2000 and 2010 in Dielmo and Ndiop, Senegal.

Authors:  Fode Diop; Vincent Richard; Babacar Diouf; Cheikh Sokhna; Nafissatou Diagne; Jean-François Trape; Michel Matar Faye; Adama Tall; Gora Diop; Aissatou Toure Balde
Journal:  Malar J       Date:  2014-03-06       Impact factor: 2.979

Review 8.  Research priorities for the development and implementation of serological tools for malaria surveillance.

Authors:  Salenna R Elliott; Freya J I Fowkes; Jack S Richards; Linda Reiling; Damien R Drew; James G Beeson
Journal:  F1000Prime Rep       Date:  2014-11-04

9.  Activation of minority-variant Plasmodium vivax hypnozoites following artesunate + amodiaquine treatment in a 23-year old man with relapsing malaria in Antananarivo, Madagascar.

Authors:  Voahangy Andrianaranjaka; Jessica T Lin; Christopher Golden; Jonathan J Juliano; Milijaona Randrianarivelojosia
Journal:  Malar J       Date:  2013-05-31       Impact factor: 2.979

10.  Seroprevalence of Plasmodium vivax in the Republic of Korea (2003-2005) using indirect fluorescent antibody test.

Authors:  Tong-Soo Kim; Yoon-Joong Kang; Won-Ja Lee; Byoung-Kuk Na; Sung-Ung Moon; Seok Ho Cha; Sung-Keun Lee; Yun-Kyu Park; Jhang-Ho Pak; Pyo Yun Cho; Youngjoo Sohn; Hyeong-Woo Lee
Journal:  Korean J Parasitol       Date:  2014-02-19       Impact factor: 1.341

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.